Neuromuscular Disorders :: Nationwide Children's Hospital

Featured Physician

Jerry Mendell, MD Jerry Mendell, MD
In 2004, Jerry Mendell, MD, was awarded the S. Mouchly Small Scientific Achievement Award from the Muscular Dystrophy Association, recognizing researchers who make significant contributions to neuromuscular disease research.

Learn more »

featured video

Christopher Walker, PhD, discusses how dystrophin immunity may contribute to muscle disease and complicate experimental therapies.
Gene Therapy Reveals Unexpected Immunity
Jerry Mendell, MD, Director of the Center for Gene Therapy, discusses how being designated as a Wellstone Center will help advance muscular dystrophy research related to immunity.
Nationwide Children's Hospital Designated as Wellstone Center

Wellstone Center Designation

 
 

Jerry Mendell, MD, discusses ongoing muscular dystrophy research efforts at The Research Institute at Nationwide Children's Hospital.

Neuromuscular Disorders

At Nationwide Children's Neuromuscular Disorders Program, a multi-disciplinary staff diagnoses and treats disorders affecting peripheral nerves and muscles in children, such as muscular dystrophy, myositis and congenital myopathy.

Muscular dystrophy is usually seen in children before the age of 5, with weakness typically affecting the shoulder and pelvic muscles. While each child may have different experiences, some common symptoms include:

  • Muscle pain or weakness

  • Muscle atrophy or enlargement

  • Swallowing problems

  • Shortness of breath

We hope this web site helps you learn more about Neuromuscular Disorders and Nationwide Children's Hospital. On our site you can:

 

 Download our Neuromuscular Disorders brochure.

Dr. Jerry Mendell Receives Endowed Chair

Dr. Mendell recognized for numerous contributions to the field of neuromuscular disease.

Listen Now: Podcasts Dedicated to the Latest Neuromuscular Research

Hosted by Kevin Flanigan, MD, "This Month in Muscular Dystrophy" podcasts highlight the latest in muscular dystrophy and other inherited neuromuscular disease research.  During each podcast, authors of recent publications discuss how their work improves our understanding of inherited neuromuscular diseases, and what their work might mean for treatment of these diseases.

MDA and AVI BioPharma opened a phase-two trial of the exon-skipping drug eteplirsen on Aug. 15, 2011, at Nationwide Children's Hospital. Learn more about this ground-breaking clinical trial.

 

Simplified Newborn Screening for Duchenne Muscular Dystrophy Shows Promise as an International Model 

Investigators at Nationwide Children’s Hospital have developed an approach to newborn screening for the life-threatening genetic disorder, Duchenne muscular dystrophy (DMD), and potentially other muscular dystrophies.  
Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000